Clinical Trial Update: Targeted Therapy and Avelumab in Merkel Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes ongoing Phase 1 and Phase 2 studies evaluating a targeted therapy in combination with avelumab for metastatic Merkel cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• Targeted therapy

Snippet

Sponsor: Melanoma and Skin Cancer Trials Limited | Conditions: Metastatic Merkel Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING